UnitedHealth Group Incorporated (UNH) FY2024 Q1 P&L / Income Statement

UnitedHealth Group Incorporated (UNH) FY2024 Q1 P&L / Income Statement

Income statement for 2024-01-01 through 2024-03-31. View: Business segment. Revenue and operating expenses use the reported business segments, including every corporate reconciling item. Segment operating costs are calculated as segment revenue less reported segment operating income.

Total revenues

99,796,000,000 US dollars

Total operating costs

91,865,000,000 US dollars

Earnings from operations

7,931,000,000 US dollars

Other income (expense), net (calculated)

negative 7,930,000,000 US dollars

Earnings before income taxes

1,000,000 US dollars

Provision for income taxes

1,222,000,000 US dollars

Net (loss) earnings

negative 1,221,000,000 US dollars

Optum Health

26,731,000,000 US dollars

Optum Insight

4,502,000,000 US dollars

Optum Rx

30,835,000,000 US dollars

UnitedHealthcare

75,357,000,000 US dollars

Optum Health costs (calculated)

24,832,000,000 US dollars

Optum Insight costs (calculated)

4,012,000,000 US dollars

Optum Rx costs (calculated)

29,688,000,000 US dollars

UnitedHealthcare costs (calculated)

70,962,000,000 US dollars

Reconciling items (calculated)

negative 37,629,000,000 US dollars

Revenue before reconciliation (calculated)

137,425,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Optum Eliminations

negative 1,016,000,000 US dollars. Reported reconciliation to consolidated revenue.

Corporate and Eliminations

negative 36,613,000,000 US dollars. Reported reconciliation to consolidated revenue.

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
• Of which attributable to UnitedHealth Group Incorporated: −$1.41 B; to noncontrolling interests: $188.00 M.